Today: 9 June 2026
Klaviyo stock drops nearly 10% to start 2026 as yields rise — what investors watch next
4 January 2026
1 min read

Klaviyo stock drops nearly 10% to start 2026 as yields rise — what investors watch next

NEW YORK, January 4, 2026, 10:48 ET — Market closed

  • Klaviyo shares fell 9.7% on Friday, sliding with high-growth software as Treasury yields firmed.
  • Peers HubSpot, Braze and Salesforce also dropped, while a broad software ETF underperformed.
  • Focus shifts to U.S. jobs data this week and Klaviyo’s next earnings timing.

Klaviyo, Inc. (KVYO) shares ended the first trading day of 2026 down 9.7% on Friday at $29.32. The stock traded between $32.46 and $29.15 and saw about 4.9 million shares change hands.

The move matters because Klaviyo sits in the high-growth software bucket, where valuations often swing with changes in interest-rate expectations. When bond yields rise, investors tend to pay less for profits that are expected further out.

With U.S. markets closed on Sunday, attention turns to whether Friday’s slide was a one-day reset or the start of a broader rotation out of rate-sensitive growth names. Traders will also look for catalysts that can reprice the Fed outlook before the next round of company earnings.

On Friday, U.S. Treasury yields moved higher and value stocks outperformed growth as markets opened the year, Reuters reported. “Value is outperforming growth,” said Jed Ellerbroek, a portfolio manager at Argent Capital in St. Louis. Reuters

The weakness was not confined to Klaviyo. HubSpot fell 4.7%, Braze slid 5.1% and Salesforce dropped 4.3%, while the iShares Expanded Tech-Software Sector ETF — a basket of software shares that trades like a stock — fell 2.9%.

Zacks Investment Research on Jan. 3 assigned Klaviyo its top “Rank 1 (Strong Buy)” rating and cited upward estimate revisions over the past 60 days. The report listed Klaviyo’s 52-week range at $23.44 to $49.55, putting the shares about 41% below the past year’s high.

Klaviyo sells software that helps consumer brands automate marketing messages across email, text messages and push notifications — prompts sent to phones or browsers. Investors tend to treat the stock as a read-through on digital marketing budgets at e-commerce-focused companies.

For the company, the next test is whether revenue growth holds up after the holiday season while management keeps a close watch on profitability. Customer retention and the cost to acquire new customers will likely stay front and center in the next update.

But the downside scenario is straightforward: if yields keep moving higher on firm economic data, investors can continue to cut exposure to smaller growth software regardless of company execution. A conservative outlook from management, when it reports, would add to that pressure.

Competition remains another watchpoint. Larger platforms and specialist customer-engagement vendors — including Salesforce, HubSpot and Braze — can pressure pricing and raise customer churn risk in a softer demand environment.

Macro catalysts come quickly. Investors will parse the U.S. jobs report due Jan. 9 and the consumer price index on Jan. 13 for clues on whether the Fed has room to keep cutting rates, Reuters reported.

Stock Market Today

  • Aker BP Share Price Surges Amid Valuation Debate
    June 9, 2026, 11:54 AM EDT. Aker BP (OB:AKRBP) shares climbed to NOK347.7, marking a 55.05% total shareholder return over one year, outperforming peers in Norway's energy sector. Despite this momentum, the stock trades at an 8.6% premium over a fair value of NOK320.11, raising questions about valuation. The company aims to sustain production above 500,000 barrels per day past 2030, backed by projects like Yggdrasil and Johan Sverdrup, supporting revenue growth. Yet, potential risks include higher emissions costs and delays in key developments. Analysts offer cautious pricing, but a discounted cash flow (DCF) model from Simply Wall St suggests a much higher intrinsic value of NOK1,769.75, indicating significant undervaluation. Investors face a valuation divide between conservative targets and optimistic cash flow projections.

Latest articles

Paranovus Stock Rockets 620% as $195 Million Share-Sale Filing Changes the Story

Paranovus Stock Rockets 620% as $195 Million Share-Sale Filing Changes the Story

9 June 2026
Paranovus Entertainment shares soared 620% to $6.76 after filing to potentially sell up to $195 million in new stock—an amount far exceeding its $7.14 million market cap—raising major dilution risks for investors as the company eyes acquisitions but warns that future share sales could pressure the stock price or threaten operations.
Coupang Stock Gains as Privacy Ruling Approaches

Coupang Stock Gains as Privacy Ruling Approaches

9 June 2026
Coupang shares jumped 2% to $15.49, outperforming a falling market, as investors braced for South Korea’s privacy regulator to decide June 10 on possible sanctions over a data breach exposing 33.6 million records—a ruling that could trigger fines up to 3% of sales and impact the stock’s recovery.
AEP’s $78 Billion Grid Plan Spurs Data Center Hopes

AEP’s $78 Billion Grid Plan Spurs Data Center Hopes

9 June 2026
AEP lifted its five-year capital plan to $78 billion after signing 7 gigawatts of new large-energy project agreements, with 90% of 63 gigawatts of expected incremental load by 2030 tied to data centers; shares recently traded at $127.27, up 26.9% over 52 weeks, with analysts’ mean price target at $142.76, as investors weigh execution risks and a new data-center rate structure.
Dow climbs in New York, but gains may stall

Dow climbs in New York, but gains may stall

9 June 2026
Dow jumps 154.87 points as tech rebounds and oil prices drop, with chipmakers like Intel and Broadcom up sharply; investors brace for Wednesday’s key inflation data and next week’s Fed meeting, which could sway rate expectations and market direction.
U.S. Stocks Hit Records This Week — Why the S&P 500 and Nasdaq Rally Survived the Oil Shock

Dow Up While Nasdaq Dips; AI Rally Meets Inflation Data

9 June 2026
Nuvalent soared after GSK agreed to buy the cancer drug developer for $10.6 billion in cash, valuing shares at $124—a 40% premium to Monday’s close—while investors awaited Wednesday’s key inflation data that could impact market direction and tech stock stability.
RIOT stock jumps after Riot Platforms names new CFO and ties bonuses to data-center deals
Previous Story

RIOT stock jumps after Riot Platforms names new CFO and ties bonuses to data-center deals

Tesco issues urgent “do not eat” recall for three pate lines after date-label error
Next Story

Tesco issues urgent “do not eat” recall for three pate lines after date-label error

Go toTop